1
|
Belmokhtar KY, Tajir M, Boulouiz R, Bennani A, Brahmi SA, Alloubi I, Kouismi H, Kamaoui I, Skiker I, Afqir S, Abda N, Bellaoui M, Mezouar L. [Lung cancer in Eastern Morocco: where do we stand?]. Pan Afr Med J 2019; 34:177. [PMID: 32153717 PMCID: PMC7046119 DOI: 10.11604/pamj.2019.34.177.19934] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2019] [Accepted: 10/29/2019] [Indexed: 01/22/2023] Open
Abstract
Introduction Lung cancer is the most common cancer in men living Eastern Morocco. We here present the first report on the clinical, pathological and therapeutic features of lung cancer in Eastern Morocco. Methods We conducted a retrospective study of 738 patients diagnosed with lung cancer at the Hassan II, Oncology Center between October 2005 and December 2014. Results Among the cases studied, 671 patients were men and 67 women; 95.01% of men and 1.54% of women were smokers. The average age of patients was 59.1 ± 11.9 years. Most patients (97%) were diagnosed at advanced stage disease. Only 4 out of 227 patients with advanced adenocarcinoma underwent molecular test. In addition, no patient in our series received targeted therapy. In this series, 20.46% of patients had less than 50 years. Compared to patients aged 50 years and older, cannabis consumption was higher (p<0.001) in patients less than 50 years and as well as a higher rate of adenocarcinoma (p<0.01). By contrast, in these patients, tobacco consumption was lower (p<0.001) as well as the rate of squamous cell carcinoma (p<0.01) and small cell cancer (p<0.05). Conclusion Unlike Western countries, in Eastern Morocco lung cancer is diagnosed late, affects younger people and access to molecular tests is still very limited. These results justify the need to implement effective programs against lung cancer as well as to facilitate access to molecular tests and new therapeutic tools in Eastern Morocco.
Collapse
Affiliation(s)
- Karam Yahya Belmokhtar
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Mariam Tajir
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Redouane Boulouiz
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Amal Bennani
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Sami Aziz Brahmi
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco.,Hassan II Oncology Center, Oujda, Morocco
| | - Ihsan Alloubi
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Hatim Kouismi
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Imane Kamaoui
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Imane Skiker
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Said Afqir
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco.,Hassan II Oncology Center, Oujda, Morocco
| | - Naima Abda
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Mohammed Bellaoui
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Loubna Mezouar
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco.,Hassan II Oncology Center, Oujda, Morocco
| |
Collapse
|